Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Impact of DPD Activity on the Efficacy of Capecitabine

NCT04198727 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.

NCT NCT04198727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04198727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
Lead sponsor
Centre Antoine Lacassagne
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 20, 2020
Completion date
July 31, 2030
Enrollment
155 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm malignant female